Publicaciones (132) Publicaciones en las que ha participado algún/a investigador/a

2017

  1. 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination

    Journal of Neuroscience, Vol. 37, Núm. 35, pp. 8385-8398

  2. 55 urtetik gorako ikasleen onura psikologikoa Euskal Herriko Unibertsitateko

    Gaceta Medica de Bilbao, Vol. 114, Núm. 1, pp. 9-14

  3. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

    Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577

  4. A neurocognitive approach for recovering upper extremity movement following subacute stroke: A randomized controlled pilot study

    Journal of Physical Therapy Science, Vol. 29, Núm. 4, pp. 665-672

  5. A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain

    BMC Geriatrics, Vol. 17, Núm. 1, pp. 1-10

  6. A simulation model of neuroprogenitor proliferation dynamics predicts age-related loss of hippocampal neurogenesis but not astrogenesis

    Scientific Reports, Vol. 7, Núm. 1

  7. A standardized protocol for stereotaxic intrahippocampal administration of kainic acid combined with electroencephalographic seizure monitoring in mice

    Frontiers in Neuroscience, Vol. 11, Núm. MAR

  8. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction

    Brain, Vol. 140, Núm. 4, pp. 1128-1146

  9. Anatomical characterization of the cannabinoid CB1 receptor in cell-type–specific mutant mouse rescue models

    Journal of Comparative Neurology, Vol. 525, Núm. 2, pp. 302-318

  10. Asociaciones de pacientes y autorización de nuevos fármacos en estados unidos. El caso del eteplirseno para la distrofia muscular de duchenne

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 373-380

  11. Assessment of predictors of the impact of fibromyalgia on health-related quality of life 12 months after the end of an interdisciplinary treatment

    Journal of Affective Disorders, Vol. 208, pp. 76-81

  12. Assessment of the consequences of caregiving in psychosis: A psychometric comparison of the Zarit Burden Interview (ZBI) and the Involvement Evaluation Questionnaire (IEQ)

    Health and Quality of Life Outcomes, Vol. 15, Núm. 1

  13. Automatic migraine classification via feature selection committee and machine learning techniques over imaging and questionnaire data

    BMC Medical Informatics and Decision Making, Vol. 17, Núm. 1

  14. Autophagy and microglia: Novel partners in neurodegeneration and aging

    International Journal of Molecular Sciences, Vol. 18, Núm. 3

  15. Building Bridges through Science

    Neuron

  16. Cambios en la resonancia magnética cerebral asociados al síndrome de fibromialgia

    Medicina Clinica, Vol. 148, Núm. 11, pp. 511-516

  17. Cannabis Use and First-Episode Psychosis Patients (FEP)

    Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (Elsevier Inc.), pp. 257-266

  18. Cannabis use, COMT, BDNF and age at first-episode psychosis

    Psychiatry Research, Vol. 250, pp. 38-43

  19. Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy

    Seizure, Vol. 45, pp. 56-60

  20. Characterization of functional μ opioid receptor turnover in rat locus coeruleus: an electrophysiological and immunocytochemical study

    British Journal of Pharmacology, Vol. 174, Núm. 16, pp. 2758-2772